Page last updated: 2024-08-25

chitosan and Cardiomegaly

chitosan has been researched along with Cardiomegaly in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhadra, U; Chatterjee, E; Chawla-Sarkar, M; Datta, K; Pal-Bhadra, M; Pramanik, A; Pramanik, P; Rana, S; Reddy, TL; Sarkar, S; Sen, P1
Banerjee, D; Datta, R; Mitra, A; Naskar, S; Rana, S; Ray, A; Sarkar, S1

Other Studies

2 other study(ies) available for chitosan and Cardiomegaly

ArticleYear
A spatio-temporal cardiomyocyte targeted vector system for efficient delivery of therapeutic payloads to regress cardiac hypertrophy abating bystander effect.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Feb-28, Volume: 200

    Topics: Animals; Bystander Effect; Carbazoles; Cardiomegaly; Cardiotonic Agents; Carvedilol; Cells, Cultured; Chitosan; Drug Delivery Systems; Gene Transfer Techniques; Humans; Myocytes, Cardiac; Nanoparticles; Peptides; Propanolamines; Rats, Wistar; RNA, Small Interfering; Stearic Acids; Tissue Engineering; Tumor Suppressor Protein p53

2015
Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment.
    Toxicology and applied pharmacology, 2016, Jan-01, Volume: 290

    Topics: Acetylation; Animals; Apoptosis; bcl-2-Associated X Protein; Biological Availability; Cardiomegaly; Caspase 3; Cell Survival; Chitosan; Curcumin; Cytochromes c; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Delivery Systems; E1A-Associated p300 Protein; Myocardium; Myocytes, Cardiac; Nanoparticles; Rats; Rats, Wistar; Tumor Suppressor Protein p53

2016